Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

13/04/2020 09:00

Apr 13 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 29, 2020        Feb 28, 2019     May 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               38.59               38.51            51.60    
                   (+0.2 pct)          (-5.9 pct)       (-0.3 pct)  
  Operating          765 mln             281 mln          905 mln   
                  (+172.0 pct)         (-70.6 pct)      (+41.3 pct) 
  Recurring          747 mln             218 mln          850 mln   
                  (+241.7 pct)         (-75.4 pct)      (+43.9 pct) 
  Net                705 mln          loss 110 mln        391 mln   
  EPS               74.21 yen        loss 12.14 yen      40.87 yen  
  EPS Diluted       60.00 yen                                       
  Ann Div                               14.00 yen        14.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T